Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care Alone in Patients With Advanced Colorectal Adenocarcinoma Refractory to Standard Therapies

Status:

Closed to Accrual

Phase

Palliative

Line of Therapy

Advanced / Metastatic

Disease Stage

Biomarker(s)

N/A

Investigational

Product

Durvalumab +Tremelimumab

Treatment Arms

o Experimental: Durvalumab plus Tremelimumab and Best Supportive Care

o Active Comparator: Best Supportive Care